EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.
(Score: 2) by FatPhil on Tuesday August 23 2016, @02:56PM
You are still seeing the free market even if it's not doing what you want a free market to do. But you're right, blaming the free market is wrong, as the invisible hand is actually a back-hander (and yes, that is deliberately a 3-way play on words).
Great minds discuss ideas; average minds discuss events; small minds discuss people; the smallest discuss themselves